Research shows routine follow-up misses most relapses in lymphoma patients in remission, highlighting the need for improved ...
Micron Biomedical, an Atlanta-based life sciences company, has received funding for its technology that could improve vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback